+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gene Therapy CDMO Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis

  • PDF Icon

    Report

  • January 2026
  • Region: Global
  • The Insight Partners
  • ID: 6285109
Description Jump to:
The gene therapy CDMO market size is expected to grow from US$ 2.60 billion in 2025 to US$ 14.17 billion by 2034; it is projected to register a CAGR of 20.3% during 2026-2034. The increasing prevalence of chronic and genetic diseases, surging regulatory approvals and commercialization, and growing popularity of outsourcing gene therapy manufacturing by companies are noteworthy factors contributing to the expansion of the gene therapy CDMO market size. Additionally, the growing demand for personalized and rare disease therapies are projected to bring new gene therapy CDMO market trends in the near future.

The market experiences a transformation because automation and digitalization bring better efficiency and scalability and improved quality control. The technologies solve complex challenges which arise from developing personalized therapies because they minimize the need for human participation while they streamline the procedures which handle viral vector production and cell expansion. CDMOs implement process analytical technologies to monitor their operations in real time which allows them to adjust their processing methods while maintaining simultaneous production of multiple items. Digital twins use their predictive capabilities to forecast how cells will react under different testing conditions, which helps to improve factory processes. The combination of Sartorius's MODDE software with Ambr 15 bioreactors demonstrates how digital twin technology enables optimization through virtual twin systems. The process of viral vector optimization achieved a significant reduction in experimental duration to three weeks from eight weeks while it generated a tenfold rise in infectious titer through precise adjustment of pH and cell density parameters.

The use of machine learning algorithms together with predictive capabilities enables CDMOs to implement proactive measures which decrease operational interruptions while enhancing the therapeutic product quality and quantity. In October 2024, OmniaBio opened its new commercial-ready manufacturing facility and AI center of excellence in Hamilton, Ontario, Canada. The facility which covers 100,000 square feet stands among the biggest CDMOs which focus on manufacturing cell and gene therapies.

The regulatory requirements for gene therapy manufacturing necessitate organizations to collect and analyze extensive data throughout their manufacturing processes. AI and digital tools enable seamless data integration, ensuring that all necessary documentation is complete and accurate for regulatory review. CDMOs that use AI together with digital platforms can effectively handle the complex nature of regulatory submission processes while they maintain compliance with changing industry requirements.

Automation together with artificial intelligence and digital analytics systems has become the key approach for CDMOs to achieve operational efficiency through their implementation, thereby emerging as a significant trend in the gene therapy CDMO market.

End User-Based Insights

Based on end user, the gene therapy CDMO market is segmented into pharmaceutical companies, biopharmaceutical companies, and other end users. The biopharmaceutical companies segment held the largest gene therapy CDMO market share in 2025. The gene therapy CDMO market is mainly controlled by biopharmaceutical companies which include small biotech firms and startup companies that need outside help for their product development and manufacturing activities. The company's expansion results from its incomplete internal capacity combined with expensive research and development expenses and the difficult nature of gene therapy treatments which need special medical facilities and expert technical knowledge that the company usually does not possess. The company uses outsourcing to improve its clinical pipeline development process while maintaining its budget for research and development activities. The expanding gene therapy pipeline, with thousands of assets in development, creates increasing demand as biotechs require trustworthy partners for their needs in viral vector production and process optimization and GMP manufacturing services. Key examples include collaborations with leading CDMOs like Lonza and Catalent which support numerous biotech programs in oncology and rare diseases. Gilead Sciences (via Kite Pharma) and Amgen have also used CDMO services for their advanced development of gene-modified therapies. The biotechs use CDMO services to overcome their regulatory challenges which enables them to bring products to market faster, thereby fueling the gene therapy CDMO market growth.

The World Health Organization and Australian Institute of Health and Welfare are among the primary and secondary sources referred to while preparing the gene therapy CDMO market report.

Reasons to Buy

● Saves and reduces time required for identifying the market growth, size, leading players, and segments in the global Gene Therapy CDMO market.
● Highlights key business priorities to assist companies in realigning their business strategies
● Emphasizes key findings and recommendations that uncover emerging industry trends in the global Gene Therapy CDMO market, enabling stakeholders across the value chain to craft effective long-term strategies
● Develop/modify business expansion plans by analyzing substantial growth prospects in mature and emerging markets
● Scrutinizes in-depth global Gene Therapy CDMO market trends, along with factors driving the market, as well as those hindering it
● Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table of Contents

1. Executive Summary
1.1 Analyst Market Outlook
1.2 Market Attractiveness
2. Gene Therapy CDMO Market Landscape
2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
2.3.1 List of Manufacturers/Suppliers
2.3.2 List of Potential Customers (Upto 50)
2.4 Porter`s Five Force Analysis
2.5 PEST Analysis
2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
2.6.1 Import-Export Analysis for Key Countries
2.7 Impact of Artificial Intelligence (AI)
2.8 Product or Technology Roadmap
2.9 Sustainability and ESG Trends
2.10 Patent Analysis
2.11 Regulatory Framework
3. Competitive Landscape
3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 - By Key Players
3.3 Market Concentration
4. Gene Therapy CDMO Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic and Genetic Diseases
4.1.2 Surging Regulatory Approvals and Commercialization
4.1.3 Growing Popularity of Outsourcing Gene Therapy Manufacturing by Companies
4.2 Market Restraints
4.2.1 High Manufacturing Costs
4.2.2 Complexities in Manufacturing Processes
4.2.3 Complex Regulatory and Compliance Requirements
4.3 Market Opportunities
4.3.1 Increased Clinical Trials for Innovative Therapies
4.3.2 Strategic Initiatives by Companies
4.3.3 Expansion of Commercial Manufacturing Services
4.4 Future Trends
4.4.1 Advanced Automation and Digitalization
4.4.2 Personalized and Rare Disease Therapies Demand
4.4.3 Scalable Viral Vector and Next Gen Production Technologies
4.5 Impact of Drivers and Restraints
5. Gene Therapy CDMO Market - Global Market Analysis
5.1 Gene Therapy CDMO Market Revenue (US$ Million), 2021-2034
5.2 Gene Therapy CDMO Market Forecast and Analysis
6. Gene Therapy CDMO Market Revenue Analysis -Service Type
6.1 Gene Therapy CDMO Market Forecasts and Analysis by Service Type
6.1.1 Drug Development and Manufacturing
6.1.1.1 Overview
6.1.1.2 Drug Development and Manufacturing: Gene Therapy CDMO Market -Revenue, 2021-2034 (US$ Million)
6.1.2 Testing and Regulatory Services
6.1.2.1 Overview
6.1.2.2 Testing and Regulatory Services: Gene Therapy CDMO Market -Revenue, 2021-2034 (US$ Million)
6.1.3 Other Service Types
6.1.3.1 Overview
6.1.3.2 Other Service Types: Gene Therapy CDMO Market -Revenue, 2021-2034 (US$ Million)
7. Gene Therapy CDMO Market Revenue Analysis -End User
7.1 Gene Therapy CDMO Market Forecasts and Analysis by End User
7.1.1 Pharmaceutical Companies
7.1.1.1 Overview
7.1.1.2 Pharmaceutical Companies: Gene Therapy CDMO Market -Revenue, 2021-2034 (US$ Million)
7.1.2 Biopharmaceutical Companies
7.1.2.1 Overview
7.1.2.2 Biopharmaceutical Companies: Gene Therapy CDMO Market -Revenue, 2021-2034 (US$ Million)
7.1.3 Other End Users
7.1.3.1 Overview
7.1.3.2 Other End Users: Gene Therapy CDMO Market -Revenue, 2021-2034 (US$ Million)
8. Gene Therapy CDMO Market - Geographical Analysis
8.1 North America
8.1.1 North America Gene Therapy CDMO Market Overview
8.1.2 North America: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.1.3 North America: Gene Therapy CDMO Market- By Segmentation
8.1.3.1 Service Type
8.1.3.2 End User
8.1.4 North America: Gene Therapy CDMO Market Breakdown by Countries
8.1.4.1 United States Market
8.1.4.1.1 United States: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.1.4.1.2 United States: Gene Therapy CDMO Market- By Segmentation
8.1.4.1.2.1 Service Type
8.1.4.1.2.2 End User
8.1.4.2 Canada Market
8.1.4.2.1 Canada: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.1.4.2.2 Canada: Gene Therapy CDMO Market- By Segmentation
8.1.4.2.2.1 Service Type
8.1.4.2.2.2 End User
8.1.4.3 Mexico Market
8.1.4.3.1 Mexico: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.1.4.3.2 Mexico: Gene Therapy CDMO Market- By Segmentation
8.1.4.3.2.1 Service Type
8.1.4.3.2.2 End User
8.2 Europe
8.2.1 Europe Gene Therapy CDMO Market Overview
8.2.2 Europe: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.2.3 Europe: Gene Therapy CDMO Market- By Segmentation
8.2.3.1 Service Type
8.2.3.2 End User
8.2.4 Europe: Gene Therapy CDMO Market Breakdown by Countries
8.2.4.1 Germany Market
8.2.4.1.1 Germany: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.2.4.1.2 Germany: Gene Therapy CDMO Market- By Segmentation
8.2.4.1.2.1 Service Type
8.2.4.1.2.2 End User
8.2.4.2 United Kingdom Market
8.2.4.2.1 United Kingdom: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.2.4.2.2 United Kingdom: Gene Therapy CDMO Market- By Segmentation
8.2.4.2.2.1 Service Type
8.2.4.2.2.2 End User
8.2.4.3 France Market
8.2.4.3.1 France: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.2.4.3.2 France: Gene Therapy CDMO Market- By Segmentation
8.2.4.3.2.1 Service Type
8.2.4.3.2.2 End User
8.2.4.4 Italy Market
8.2.4.4.1 Italy: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.2.4.4.2 Italy: Gene Therapy CDMO Market- By Segmentation
8.2.4.4.2.1 Service Type
8.2.4.4.2.2 End User
8.2.4.5 Spain Market
8.2.4.5.1 Spain: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.2.4.5.2 Spain: Gene Therapy CDMO Market- By Segmentation
8.2.4.5.2.1 Service Type
8.2.4.5.2.2 End User
8.2.4.6 Rest of Europe Market
8.2.4.6.1 Rest of Europe: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.2.4.6.2 Rest of Europe: Gene Therapy CDMO Market- By Segmentation
8.2.4.6.2.1 Service Type
8.2.4.6.2.2 End User
8.3 Asia Pacific
8.3.1 Asia Pacific Gene Therapy CDMO Market Overview
8.3.2 Asia Pacific: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.3.3 Asia Pacific: Gene Therapy CDMO Market- By Segmentation
8.3.3.1 Service Type
8.3.3.2 End User
8.3.4 Asia Pacific: Gene Therapy CDMO Market Breakdown by Countries
8.3.4.1 China Market
8.3.4.1.1 China: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.3.4.1.2 China: Gene Therapy CDMO Market- By Segmentation
8.3.4.1.2.1 Service Type
8.3.4.1.2.2 End User
8.3.4.2 Japan Market
8.3.4.2.1 Japan: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.3.4.2.2 Japan: Gene Therapy CDMO Market- By Segmentation
8.3.4.2.2.1 Service Type
8.3.4.2.2.2 End User
8.3.4.3 India Market
8.3.4.3.1 India: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.3.4.3.2 India: Gene Therapy CDMO Market- By Segmentation
8.3.4.3.2.1 Service Type
8.3.4.3.2.2 End User
8.3.4.4 Australia Market
8.3.4.4.1 Australia: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.3.4.4.2 Australia: Gene Therapy CDMO Market- By Segmentation
8.3.4.4.2.1 Service Type
8.3.4.4.2.2 End User
8.3.4.5 South Korea Market
8.3.4.5.1 South Korea: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.3.4.5.2 South Korea: Gene Therapy CDMO Market- By Segmentation
8.3.4.5.2.1 Service Type
8.3.4.5.2.2 End User
8.3.4.6 Rest of APAC Market
8.3.4.6.1 Rest of APAC: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.3.4.6.2 Rest of APAC: Gene Therapy CDMO Market- By Segmentation
8.3.4.6.2.1 Service Type
8.3.4.6.2.2 End User
8.4 Middle East and Africa
8.4.1 Middle East and Africa Gene Therapy CDMO Market Overview
8.4.2 Middle East and Africa: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.4.3 Middle East and Africa: Gene Therapy CDMO Market- By Segmentation
8.4.3.1 Service Type
8.4.3.2 End User
8.4.4 Middle East and Africa: Gene Therapy CDMO Market Breakdown by Countries
8.4.4.1 Saudi Arabia Market
8.4.4.1.1 Saudi Arabia: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.4.4.1.2 Saudi Arabia: Gene Therapy CDMO Market- By Segmentation
8.4.4.1.2.1 Service Type
8.4.4.1.2.2 End User
8.4.4.2 South Africa Market
8.4.4.2.1 South Africa: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.4.4.2.2 South Africa: Gene Therapy CDMO Market- By Segmentation
8.4.4.2.2.1 Service Type
8.4.4.2.2.2 End User
8.4.4.3 United Arab Emirates Market
8.4.4.3.1 United Arab Emirates: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.4.4.3.2 United Arab Emirates: Gene Therapy CDMO Market- By Segmentation
8.4.4.3.2.1 Service Type
8.4.4.3.2.2 End User
8.4.4.4 Rest of Middle East and Africa Market
8.4.4.4.1 Rest of Middle East and Africa: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.4.4.4.2 Rest of Middle East and Africa: Gene Therapy CDMO Market- By Segmentation
8.4.4.4.2.1 Service Type
8.4.4.4.2.2 End User
8.5 South and Central America
8.5.1 South and Central America Gene Therapy CDMO Market Overview
8.5.2 South and Central America: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.5.3 South and Central America: Gene Therapy CDMO Market- By Segmentation
8.5.3.1 Service Type
8.5.3.2 End User
8.5.4 South and Central America: Gene Therapy CDMO Market Breakdown by Countries
8.5.4.1 Brazil Market
8.5.4.1.1 Brazil: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.5.4.1.2 Brazil: Gene Therapy CDMO Market- By Segmentation
8.5.4.1.2.1 Service Type
8.5.4.1.2.2 End User
8.5.4.2 Argentina Market
8.5.4.2.1 Argentina: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.5.4.2.2 Argentina: Gene Therapy CDMO Market- By Segmentation
8.5.4.2.2.1 Service Type
8.5.4.2.2.2 End User
8.5.4.3 Rest of South and Central America Market
8.5.4.3.1 Rest of South and Central America: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
8.5.4.3.2 Rest of South and Central America: Gene Therapy CDMO Market- By Segmentation
8.5.4.3.2.1 Service Type
8.5.4.3.2.2 End User
9. Gene Therapy CDMO Market Industry Landscape
10. Gene Therapy CDMO Market - Key Company Profiles
10.1 WuXi Biologics Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Charles River Laboratories International Inc
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Catalent Inc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Lonza Group AG
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 National Resilience Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Thermo Fisher Scientific Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 AGC Biologics AS
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Takara Bio Inc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 FUJIFILM Holdings Corp
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 SK pharmteco Inc
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 Glossary
11.4 Research Methodology and Approach
11.4.1 Secondary Research
11.4.2 Primary Research
11.4.3 Market Estimation Approach
11.4.3.1 Supply Side Analysis
11.4.3.2 Demand Side Analysis
11.4.4 Research Assumptions and Limitations
11.4.5 Currency Conversion
11.5 About the Analyst
11.6 Market Intelligence Cloud
LIST OF TABLES
Table 1. List of Patents and Description
Table 2. List of Regulatory Bodies and Organizations
Table 3. Ease of Doing Business: Key Country Rankings
Table 4. Market Share Analysis, 2025 - By Key Players
Table 5. Gene Therapy CDMO Market - Revenue, 2021-2025(US$ Million)
Table 6. Gene Therapy CDMO Market - Revenue Forecast, 2026-2034(US$ Million)
Table 7. Gene Therapy CDMO Market - Revenue, 2021-2025(US$ Million) - by Service Type
Table 8. Gene Therapy CDMO Market - Revenue Forecast, 2026-2034(US$ Million) - by Service Type
Table 9. Gene Therapy CDMO Market - Revenue, 2021-2025(US$ Million) - by End User
Table 10. Gene Therapy CDMO Market - Revenue Forecast, 2026-2034(US$ Million) - by End User
Table 11. North America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 12. North America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 13. North America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 14. North America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 15. North America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Country
Table 16. North America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
Table 17. United States: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 18. United States: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 19. United States: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 20. United States: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 21. Canada: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 22. Canada: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 23. Canada: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 24. Canada: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 25. Mexico: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 26. Mexico: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 27. Mexico: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 28. Mexico: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 29. Europe: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 30. Europe: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 31. Europe: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 32. Europe: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 33. Europe: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Country
Table 34. Europe: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
Table 35. Germany: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 36. Germany: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 37. Germany: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 38. Germany: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 39. United Kingdom: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 40. United Kingdom: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 41. United Kingdom: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 42. United Kingdom: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 43. France: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 44. France: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 45. France: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 46. France: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 47. Italy: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 48. Italy: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 49. Italy: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 50. Italy: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 51. Spain: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 52. Spain: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 53. Spain: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 54. Spain: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 55. Rest of Europe: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 56. Rest of Europe: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 57. Rest of Europe: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 58. Rest of Europe: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 59. Asia Pacific: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 60. Asia Pacific: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 61. Asia Pacific: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 62. Asia Pacific: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 63. Asia Pacific: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Country
Table 64. Asia Pacific: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
Table 65. China: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 66. China: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 67. China: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 68. China: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 69. Japan: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 70. Japan: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 71. Japan: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 72. Japan: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 73. India: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 74. India: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 75. India: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 76. India: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 77. Australia: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 78. Australia: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 79. Australia: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 80. Australia: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 81. South Korea: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 82. South Korea: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 83. South Korea: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 84. South Korea: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 85. Rest of APAC: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 86. Rest of APAC: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 87. Rest of APAC: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 88. Rest of APAC: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 89. Middle East and Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 90. Middle East and Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 91. Middle East and Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 92. Middle East and Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 93. Middle East and Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Country
Table 94. Middle East and Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
Table 95. Saudi Arabia: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 96. Saudi Arabia: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 97. Saudi Arabia: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 98. Saudi Arabia: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 99. South Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 100. South Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 101. South Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 102. South Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 103. United Arab Emirates: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 104. United Arab Emirates: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 105. United Arab Emirates: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 106. United Arab Emirates: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 107. Rest of Middle East and Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 108. Rest of Middle East and Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 109. Rest of Middle East and Africa: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 110. Rest of Middle East and Africa: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 111. South and Central America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 112. South and Central America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 113. South and Central America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 114. South and Central America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 115. South and Central America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Country
Table 116. South and Central America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
Table 117. Brazil: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 118. Brazil: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 119. Brazil: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 120. Brazil: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 121. Argentina: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 122. Argentina: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 123. Argentina: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 124. Argentina: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 125. Rest of South and Central America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by Service Type
Table 126. Rest of South and Central America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by Service Type
Table 127. Rest of South and Central America: Gene Therapy CDMO Market - Revenue, 2021-2025 (US$ Million) - by End User
Table 128. Rest of South and Central America: Gene Therapy CDMO Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
Table 129. Glossary - Gene Therapy CDMO Market
LIST OF FIGURES
Figure 1. Gene Therapy CDMO Market - Value Chain Analysis
Figure 2. Porter’s Five Forces Analysis
Figure 3. Pest Analysis
Figure 4. Gene Therapy CDMO Market - Key Industry Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Gene Therapy CDMO Market Revenue (US$ Million), 2021-2034
Figure 7. Gene Therapy CDMO Market Share (%) - by Service Type (2025 and 2034)
Figure 8. Drug Development and Manufacturing: Gene Therapy CDMO Market -Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 9. Testing and Regulatory Services: Gene Therapy CDMO Market -Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 10. Other Service Types: Gene Therapy CDMO Market -Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 11. Gene Therapy CDMO Market Share (%) - by End User (2025 and 2034)
Figure 12. Pharmaceutical Companies: Gene Therapy CDMO Market -Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 13. Biopharmaceutical Companies: Gene Therapy CDMO Market -Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 14. Other End Users: Gene Therapy CDMO Market -Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 15. Gene Therapy CDMO Market Breakdown by Geography, 2025 and 2034
Figure 16. North America: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 17. North America: Gene Therapy CDMO Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 18. United States: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 19. Canada: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 20. Mexico: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 21. Europe: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 22. Europe: Gene Therapy CDMO Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 23. Germany: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 24. United Kingdom: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 25. France: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 26. Italy: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 27. Spain: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 28. Rest of Europe: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 29. Asia Pacific: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 30. Asia Pacific: Gene Therapy CDMO Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 31. China: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 32. Japan: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 33. India: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 34. Australia: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 35. South Korea: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 36. Rest of APAC: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 37. Middle East and Africa: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 38. Middle East and Africa: Gene Therapy CDMO Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 39. Saudi Arabia: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 40. South Africa: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 41. United Arab Emirates: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 42. Rest of Middle East and Africa: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 43. South and Central America: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 44. South and Central America: Gene Therapy CDMO Market Breakdown by Key Countries, 2025 and 2034 (%)
Figure 45. Brazil: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 46. Argentina: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 47. Rest of South and Central America: Gene Therapy CDMO Market Revenue and Forecasts, 2021-2034 (US$ Million)
Figure 48. Bottom-Up Approach and Top-Down Approach

Companies

The List of Companies - Gene Therapy CDMO Market
● WuXi Biologics Inc            
● Charles River Laboratories International Inc       
● Catalent Inc
● Lonza Group AG               
● National Resilience Inc
● Thermo Fisher Scientific Inc
● AGC Biologics AS              
● Takara Bio Inc 
● FUJIFILM Holdings Corp
● SK pharmteco Inc.

Related Topics

Related Reports

Cell and Gene Therapy Contract Development and Manufacturing Organization (Cdmo) Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Cell and Gene Therapy Contract Development and Manufacturing Organization (Cdmo) Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Biologics CDMO - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Biologics CDMO - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Cell & Gene Therapy Biomanufacturing CDMO Market - Global Forecast 2026-2032 - Product Image

Cell & Gene Therapy Biomanufacturing CDMO Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Cell and Gene Therapy CDMO Market: Analysis By Type, Application, Indication, By Region, By Country: Market Insights and Forecast - Product Image

Cell and Gene Therapy CDMO Market: Analysis By Type, Application, Indication, By Region, By Country: Market Insights and Forecast

  • Report
  • 260 Pages
  • Global
From
Cell Therapy & Gene Therapy CDMO Market - Global Forecast 2025-2030 - Product Image

Cell Therapy & Gene Therapy CDMO Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.